Neurofarmagen ADHD (for the genetic analysis of attention deficit disorder with hyperactivity) will be distributed in Spain by Laboratorios Rubio.
The AB-Biotics biotechnology has reached a marketing agreement for the company's first product reaching the market. This is a d ispositivo allowing the genetic analysis of neuropsychiatric disorders, which will distribute the Catalan pharmaceutical laboratories Rubió.
Read more.
View Neurofarmagen web.
0 comments:
Post a Comment